American Vanguard Corporation (AVD)

Market Cap	70.49M -46.1%
Revenue (ttm)	515.11M -5.9%
Net Income	-49.88M
EPS	-1.75
Shares Out	28.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	263,555
Open	2.500
Previous Close	2.450
Day's Range	2.450 - 2.607
52-Week Range	2.050 - 5.920
Beta	1.43
Analysts	Strong Buy
Price Target	12.00 (+385.83%)
Earnings Date	Mar 16, 2026

About AVD

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liq...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1969
• Employees: 739
• Stock Exchange: NYSE
• Ticker Symbol: AVD
• Website: https://www.american-vanguard.com

Financial Performance

In 2025, American Vanguard's revenue was $515.11 million, a decrease of -5.88% compared to the previous year's $547.31 million. Losses were -$49.88 million, -60.52% less than in 2024.

Analyst Summary

According to one analyst, the rating for AVD stock is "Strong Buy" and the 12-month stock price target is $12.0.

Price Target

$12.0

(385.83% upside)

Analyst Consensus: Strong Buy